Poly Medicure Ltd. News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Poly Medicure Ltd. from all sources in a single place.

Load latest

Poly Medicure Ltd.

24 May 2024

2393.50

3.15%

Company Update

POLY MEDICURE LTD. - 531768 - Compliances-Reg.24(A)-Annual Secretarial Compliance

BSE India

Pursuant to Regulation 24(a) of SEBI (LODR) Regulations, 2015, we enclose herewith Annual Secretarial Compliance Report of the Company for the financial year ended 31st March, 2024 by P.K. Mishra & Associates, Practising Company Secretaries.

pdf

Poly Medicure Ltd.

21 May 2024

2393.50

3.15%

Poly Medicure Q4 Results Review - Targeting Accelerated Growth: Systematix

NDTV Profit

Poly Medicure share of the overall disposable medical device pie in Europe is miniscule and there is very large headroom for them.

Poly Medicure Ltd. is trading below its 100 day SMA of 2438.1

Poly Medicure Ltd.

21 May 2024

2393.50

3.15%

Earnings Call

POLY MEDICURE LTD. - 531768 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Dear Sir/Madam, Pursuant to the provisions of Regulation 30 and 46(2) (oa) of the securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015, as amended, the audio recording of the Earnings Conference Call held on Monday, May 20, 2024, on the Unaudited Standalone and Consolidated financial results of the Company for the quarter ended March 31, 2024 , is available on the Company's website at https://www.polymedicure.com/wp-content/uploads/2024/05/ICI3420240520153154.mp3

pdf

Poly Medicure Ltd.

20 May 2024

2393.50

3.15%

Poly Medicure Results Earnings Call for Q4FY24

Conference Call with Poly Medicure Management and Analysts on Q4FY24 Performance and Outlook. Listen to the full earnings transcript.

audio

Poly Medicure Ltd.

17 May 2024, 07:38PM

2393.50

3.15%

Investor Presentation

POLY MEDICURE LTD. - 531768 - Announcement under Regulation 30 (LODR)-Investor Presentation

BSE India

Dear Sir, Pursuant to Regulation 30, Regulation 51 and other applicable provisions of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Investor''s Presentation with respect to Audited Financial Results for Quarter and Financial Year ended on March, 2024. The same is also available on the website of the Company i.e. www.polymedicure.com

pdf

Poly Medicure Ltd.

17 May 2024, 02:16PM

2393.50

3.15%

Company Update

POLY MEDICURE LTD. - 531768 - Compliance Of Regulation 30 (3)(D) Of SEBI (LODR) Regulations, 2015 …

BSE India

In compliance of Regulation 33(3)(d) of SEBI(LODR) Regulations, 2015, we are here by declare that M/s. M.C. Bhandari & Co. statutory Auditors of the Company have issued audit report with unmodified opinion on the audited financial results(standalone and consolidated) for the forth quarter and financial year ended on 31st MARCH, 2024.

pdf

Poly Medicure Ltd.

17 May 2024, 02:08PM

2393.50

3.15%

Result

POLY MEDICURE LTD. - 531768 - Audited Financial Results (Consolidate & Standalone) For The Fourth Quarter …

BSE India

Pursuant to Regulatiom 30 and 33 of SEBI(LODR) Regulations, 2015, we are pleased to inform the stock exchange that the board of directors of at their meeting held today i.e. 17th May, 2024, at Crowne plaza today, plot No. 1, community centre, okhla -I, New Delhi 110020, approved the Audited Financial Results (Consolidated & Standalone) for the fourth quarter and financial year ended on 31st March, 2024.

pdf

Poly Medicure Ltd.

17 May 2024, 01:47PM

2393.50

3.15%

Board Meeting

POLY MEDICURE LTD. - 531768 - Board Meeting Outcome for Outcome Of The Board Meeting Of …

BSE India

Dear Sir/Madam, Pursuant to Regulation 30 and 33 of SEBI (LODR) Regulations, 2015, We are pleased to inform the Stock Exchange that the Board of Directors at their meeting held today i.e. 17th May, 2024, at Crowne Plaza Today, Plot No.1, Community Centre, Okhla -I, New Delhi-110020, approved the following businesses: a. Audited Financial Results (Consolidate & Standalone) for the Fourth quarter and financial year ended on 31st March 2024. b. Recommendation of Dividend of Rs. 3 (Three Rupees) per Equity Shares (60%) of Rs. 5 each for the Financial Year 2023-24, subject to the approval of shareholders. c. Any Other Item. The Meeting was started at 10.30 am and concluded on 1:30 pm. Kindly take a note of the same for your further needful and oblige us.

pdf